Drug Design MRes

UCL (University College London)

This one-year, campus-based MRes Drug Design is offered by the internationally renowned UCL Division of Medicine, with support from the Wolfson Institute for Biomedical Research. You will learn from a team conducting cutting-edge research within the drug industries and UCL's academic group and have opportunities for networking and future career development. Drug design is an integral part of the pharmaceutical and biotech industries. Pharmaceutical and biotechnology companies, well established in the West, have been transferring their research and development to the East. Given these substantial developments, particularly in China and India, as a graduate of this programme, you will be well placed to explore roles in these areas. The UCL Division of Medicine and Wolfson Institute for Biomedical Research are experts in training the next generation of drug discovery biologists and chemists in the field, especially in drug discovery projects. The programme is particularly suited to research-oriented students who want to understand the drug design process, to establish a career in drug discovery or undertake further research. You will study the latest methodologies and approaches to all aspects of drug design. These include drug discovery, computational and structural biology, screening, assay development, medicinal chemistry, and most importantly the industrial practices involved in modern drug design technology. Alongside this, you will develop your skills in translational research and apply these to your own research project for six months. This MRes is ideal if you are a graduate wanting to gain a broad understanding of the drug design process, either to establish a career in drug discovery or undertake further research. It is also suitable if you are an industry professional looking to refresh your knowledge and skills and become familiar with cutting-edge drug design developments.